Skip to main content

Pseudoephedrine Dosage

Medically reviewed by Drugs.com. Last updated on Aug 10, 2023.

Applies to the following strengths: 7.5 mg/0.8 mL; 30 mg; 120 mg; 15 mg/5 mL; 60 mg; 15 mg; 240 mg; 30 mg/5 mL; 50 mg/5 mL; 22.5 mg/5 mL

Usual Adult Dose for:

Usual Pediatric Dose for:

Additional dosage information:

Usual Adult Dose for Nasal Congestion

Immediate release: 30 to 60 mg orally every 4 to 6 hours as needed
12-hour extended- release: 120 mg orally every 12 hours as needed
24-hour extended-release: 240 mg orally every 24 hours as needed
Maximum dose: 240 mg per day

Comment: Recommended doses should not be exceeded.

Uses:

Usual Pediatric Dose for Nasal Congestion

4 to 5 years:
Immediate release: 15 mg orally every 4 to 6 hours as needed
Maximum dose: 60 mg in 24 hours

6 to 12 years:
Immediate release: 30 mg orally every 4 to 6 hours as needed
Maximum dose: 120 mg in 24 hours

12 years or older:
Immediate release: 30 to 60 mg orally every 4 to 6 hours as needed
12-hour extended- release: 120 mg orally every 12 hours as needed
24-hour extended-release: 240 mg orally every 24 hours as needed
Maximum dose: 240 mg in 24 hours

Comments:


Uses:

Renal Dose Adjustments

Severe renal impairment: Use caution, especially in patients with concurrent cardiovascular disease.

Liver Dose Adjustments

Severe hepatic impairment: Use caution, especially in patients with concurrent cardiovascular disease.

Precautions

On March 9, 2006, The Combat Methamphetamine Epidemic Act of 2005 was enacted which requires sellers of this drug ensure that: employees have been trained; records of the training are being maintained; sales limits are being enforced; products are being stored appropriately; and a written or electronic logbook is being maintained. The law requires that retailers place pseudoephedrine products where customers do not have direct access to such products before a sale is made. The FDA defines pseudoephedrine as an OTC drug in accordance with the monograph and FDA regulations.

The US FDA strongly recommends that over- the- counter (OTC) cough and cold products not be used in children younger than 2 years of age because serious and potentially life-threatening side effects can occur including death, convulsions, rapid heart rates, and decreased levels of consciousness. OTC cough and cold products include decongestants, expectorants, antihistamines, and antitussives.

Safety and efficacy have not been established in patients younger than 2 years.

Consult WARNINGS section for additional precautions.

Dialysis

Data not available

Other Comments

Administration advice:
Oral Liquid:


Extended-release tablets:

Storage requirements:

General:

Patient advice:

Frequently asked questions

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.